Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for acute myocardial infarction

A technology of acute myocardial infarction and composition, which is applied in the field of pharmaceutical composition for acute myocardial infarction, and can solve the problems of low success rate of rescue of acute myocardial infarction

Inactive Publication Date: 2021-05-07
ZHANG ZHOU HALTH VOCATIONAL COLLEGE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention aims at the technical defects of the prior art, and provides a pharmaceutical composition for acute myocardial infarction, so as to solve the technical problem that the success rate of conventional drugs for acute myocardial infarction is relatively low.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A pharmaceutical composition for acute myocardial infarction, the pharmaceutical composition is composed of the following components by weight: 14 parts of Baitou, 12 parts of Pinellia, 6 parts of Tiaoling, 6 parts of Xia Wu, 3 parts of Cuscuta, and Mianma 2 parts of Guanzhong, 2 parts of forsythia, 1 part of star anise lotus, 1 part of Litsea Cubeba, 0.5 part of Dong Lingcao, 0.2 part of Styrax, 0.2 part of Liangmianzhen, 0.1 part of Eucommia ulmoides, 0.1 part of Rosa rosae, 0.05 part of Cornus officinalis, Tinglizi 0.05 part, Eupatorium 0.1 part, honeysuckle vine 0.1 part.

Embodiment 2

[0023] A pharmaceutical composition for acute myocardial infarction, the pharmaceutical composition is composed of the following components by weight: 20 parts of Baitou, 15 parts of Pinellia, 12 parts of Tiaoling, 10 parts of Xia Wu, 8 parts of Cuscuta, Mianma 6 parts of Guanzhong, 8 parts of forsythia, 4 parts of star anise lotus, 3 parts of Litsea Cubeba, 2 parts of Dong Lingcao, 0.8 part of Styrax, 1 part of Liangmianzhen, 0.4 part of Eucommia ulmoides, 0.3 part of Rosa rosae, 0.4 part of Cornus officinalis, Tinglizi 0.2 parts, Eupatorium 0.2 parts, Lonicera vine 0.2 parts.

Embodiment 3

[0025] A pharmaceutical composition for acute myocardial infarction, the pharmaceutical composition is composed of the following components by weight: 17 parts of Baitou, 13 parts of Pinellia, 8 parts of Tiaoling, 8 parts of Xia Wu, 6 parts of Cuscuta, and Mianma 4 parts of Guanzhong, 5 parts of Forsythia, 3 parts of Star Anise, 2 parts of Litsea Cubeba, 1 part of Dong Lingcao, 0.5 part of Styrax, 0.6 part of Liangmianzhen, 0.2 part of Eucommia, 0.2 part of Rosaceae, 0.3 part of Cornus officinalis, Tinglizi 0.08 parts, Eupatorium 0.17 parts, honeysuckle vine 0.12 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for acute myocardial infarction. The pharmaceutical composition is prepared from the following components in parts by weight: 14 to 20 parts of rhizoma gastrodiae, 12 to 15 parts of rhizoma pinelliae, 6 to 12 parts of poria cocos, 6 to 10 parts of rhizoma corydalis decumbentis, 3 to 8 parts of semen cuscutae, 2 to 6 parts of rhizoma dryopteris crassirhizomae, 2 to 8 parts of fructus forsythiae, 1 to 4 parts of dysosma versipellis, 1 to 3 parts of litsea cubeba, 0.5 to 2 parts of herba rabdosiae, 0.2 to 0.8 part of storax, 0.2 to 1 part of radix zanthoxyli, 0.1 to 0.4 part of cortex eucommiae, 0.1 to 0.3 part of fructus rosae laevigatae, 0.05 to 0.4 part of fructus corni, 0.05 to 0.2 part of semen lepidii, 0.1 to 0.2 part of herba lycopi and 0.1 to 0.2 part of honeysuckle stems Based on the compounding scheme, the pharmaceutical composition has a good treatment effect on acute myocardial infarction, can effectively expand blood vessels, rapidly dissolve thrombus and recover myocardial blood supply, and besides, relieves infarction focus caused by myocardial ischemia. When the composition is orally taken, the rescue success rate of acute myocardial infarction can be remarkably increased, and the occurrence rate of serious complications such as arrhythmia, heart failure and cardiac shock can be reduced.

Description

technical field [0001] The invention relates to the technical field of pharmacy, and further relates to the development of novel pharmaceutical compositions, in particular to a pharmaceutical composition for acute myocardial infarction. Background technique [0002] Acute myocardial infarction, also known as acute myocardial infarction, is myocardial necrosis caused by acute and persistent coronary ischemia and hypoxia. Clinically, there are often severe and persistent substernal pains, which cannot be completely relieved by rest and nitrates, accompanied by increased serum myocardial enzyme activity and progressive ECG changes, which may be complicated by arrhythmia, shock or heart failure, often life-threatening. The disease is most common in Europe and the United States, and about 1.5 million people in the United States suffer from myocardial infarction every year. China has shown a clear upward trend in recent years, with at least 500,000 new cases each year and at leas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8962A61K36/8968A61K36/906A61P9/10
CPCA61K36/12A61K36/185A61K36/29A61K36/31A61K36/355A61K36/39A61K36/40A61K36/43A61K36/46A61K36/47A61K36/53A61K36/538A61K36/539A61K36/54A61K36/634A61K36/66A61K36/738A61K36/758A61K36/81A61K36/888A61K36/8888A61K36/8962A61K36/8968A61K36/906A61P9/10A61K2300/00
Inventor 颜晓萍王志荣陈水椿曾文娟
Owner ZHANG ZHOU HALTH VOCATIONAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products